View source for rotation:molecualr-april2020week2

<table class='table border1px' align="center">
<tr>
<th width="10%">Time</th>
<th width="18%">Monday 4/13</th>
<th width="18%">Tuesday 4/14</th>
<th width="18%">Wednesday 4/15</th>
<th width="18%">Thursday 4/16</th>
<th width="18%">Friday 4/17</th>
</tr>
<tr>
<th>8:00–8:30</th>
<td> </td>
<td> </td>
<td bgcolor="#7DE3A0" rowspan="3">
Alex Farahani
<br>Metabase
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="3">
Alex Farahani
<br>Metabase
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td> </td>
</tr>
<tr>
<th>8:30–9:00</th>
<td> </td> 
<td> </td> 
<td bgcolor="#7DE3A0" rowspan="5">
Long P. Le, M.D., Ph.D.
<br>Markus Herrmann, M.D., Ph.D.
<br>Computational Pathology
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
</tr>
<tr>
<th>9:00–9:30</th>
<td> </td>
<td> </td>
</tr>
<tr>
<th>9:30–10:00</th>
<td bgcolor="#7DE3A0" rowspan="3">
Valentina Nardi, M.D.
<br>aCGH Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td> </td>
<td bgcolor="#7DE3A0" rowspan="2">
Dora Dias-Santagata, Ph.D.
<br>Thyroid Tumors
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="2">
Adam Fisch, M.D., Ph.D.
<br>Fusion Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
</tr>
<tr>
<th>10:00–10:30</th>
<td bgcolor="#7DE3A0" rowspan="2">
John Iafrate, M.D., Ph.D.
<br>Liquid Biopsies
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
</tr>
<tr>
<th>10:30–11:00</th>
<td> </td>
<td bgcolor="#7DE3A0" rowspan="3">
Jochen K. Lennerz, M.D., Ph.D.
<br>FISH Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
</tr>
<tr>
<th>11:00–11:30</th>
<td> </td>
<td> </td>
<td bgcolor="#7DE3A0" rowspan="2">
Lauren Ritterhouse, M.D., Ph.D.
<br>Molecular Oncology of GYN Tumors
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td> </td>
</tr>
<tr>
<th>11:30–12:00</th>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<th>12:00–1:00</th>
<td>
OUTS Conference<p></p>
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a1c503cfff4a84072b8913957f9e22c4a%40thread.skype/OUTS?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams OUTS</htmltag>
</td>
<td>
OUTS Conference<p></p>
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a1c503cfff4a84072b8913957f9e22c4a%40thread.skype/OUTS?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams OUTS</htmltag>
</td>
<td>
OUTS Conference<p></p>
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a1c503cfff4a84072b8913957f9e22c4a%40thread.skype/OUTS?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams OUTS</htmltag>
</td>
<td>
AP Lecture Series<p></p>
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a6eb1f6a50daf43b9a1ead194c925cfe8%40thread.skype/AP%2520residents?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams AP Residents</htmltag>
</td>
<td>
OUTS Conference<p></p>
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a1c503cfff4a84072b8913957f9e22c4a%40thread.skype/OUTS?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams OUTS</htmltag>
</td>
</tr>
<tr>
<th>1:00–1:30</th>
<td bgcolor="#7DE3A0" rowspan="2">
Nick Jessop
<br>Case Management
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td rowspan="2">
LMM Conference
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3addc83935c1ba4881bf3c214441deec8a%40thread.skype/CP%2520residents?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams CP Residents</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="4">
Valentina Nardi, M.D.
<br>Small Molecular/NGS Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="4">
Adam Fisch, M.D., Ph.D.
<br>SNV/Indel Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td> </td>
</tr>
<tr>
<th>1:30–2:00</th>
<td> </td>
</tr>
<tr>
<th>2:00–2:30</th>
<td bgcolor="#7DE3A0" rowspan="2">
Ryan Frazier
<br>Digital Pathology
<br>
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td rowspan="2">
Heme Molecular Conference
<br>TBD
</td>
<td bgcolor="#7DE3A0" rowspan="6">
<br>Long P. Le, M.D., Ph.D.
<br>Markus Herrmann, M.D., Ph.D.
<br>Computational Pathology
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
<br>OR 
<br>Research Talks
</td>
</tr>
<tr>
<th>2:30–3:00</th>
</tr>
<tr>
<th>3:00–3:30</th>
<td bgcolor="#7DE3A0" rowspan="2">
Valentina Nardi, M.D.
<br>AML Testing in Era of Targeted Therapies
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="4">
Jochen K. Lennerz, M.D., Ph.D.
<br>FISH Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="2">
Hetal Marble, Ph.D.
<br>Clinical Trials
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td bgcolor="#7DE3A0" rowspan="2">
Valentina Nardi, M.D.
<br>Case Review
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
</tr>
<tr>
<th>3:30–4:00</th>
</tr>
<tr>
<th>4:00–4:30</th>
<td> </td>
<td bgcolor="#7DE3A0" rowspan="2">
John Iafrate, M.D., Ph.D.
<br>Lung Cancer Update
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
</td>
<td> </td>
</tr>
<tr>
<th>4:30–5:00</th>
<td> </td>
<td> </td>
</tr>
</table>
{{ColorText|All: residents, fellows, HMS students|#7DE3A0|3}}